GeneVentiv Therapeutics Inc

  • BioTech/Drugs
  • Raleigh NC
  • 2 employees
Get Full Info

Company Overview

Website
geneventiv.com
Employees
2
Industry
BioTech/Drugs
SIC Code
8731 - Commercial Physical and Biological Research
More Details

Financials & Stats

Revenue

$3B

More Financials

Recent News & Media

13 top Biotech companies and startups in Raleigh in July 2025

  • Jul 1, 2025
  • f6s.com

GeneVentiv Announces Global Licensing Agreement for Universal Gene Editing Therapy for Infantile Onset and Late Onset Pompe Disease

  • Apr 8, 2025
  • prnewswire.com

Teams

  • Feb 12, 2025
  • southeastventureshowcase.com

Everything you need to know about NIH cuts (+ how they could cause ‘massive layoffs’ in NC)

  • Feb 11, 2025
  • charlotteobserver.com

Which NC organizations would be impacted by Trump’s NIH funding cuts? Here’s a list

  • Feb 11, 2025
  • charlotteobserver.com

AAV8-hLCA5 Subretinal Delivery to the Macula in LCA5-associated Leber Congenital Amaurosis (LCA5-LCA): Preliminary Safety and Efficacy Results of an Ongoing Phase I/II Gene Therapy Trial | IOVS | ARVO Journals

  • Jul 1, 2024
  • iovs.arvojournals.org

Who is GeneVentiv Therapeutics Inc

GeneVentiv Therapeutics Inc. is a privately held gene therapy company based in Raleigh, North Carolina. The company employs two individuals and has reported revenue of $2.5 million. GeneVentiv Therapeutics specializes in developing gene therapies for patients with Hemophilia A and Hemophilia B, including those with inhibitors who are unable to respond to current therapies. Their research focuses on leveraging Adeno Associated Virus (AAV) directed gene therapy and the clotting cascade to overcome the challenge posed by neutralizing antibodies. The company aims to provide a single, life-changing infusion that offers a cure, as opposed to weekly injections of bypass agents. GeneVentiv Therapeutics is in the Investigational New Drug (IND) enabling stage of development, working towards bringing the first effective gene therapy for Hemophilia to market. For more information about GeneVentiv Therapeutics Inc., please visit www.geneventiv.com.

Company Leadership

Damon Race

CEO

Phone Email
Chengwen Li

Co-Founder, Scientific Advisor

Phone Email
Paris Margaritis

Consulting CSO

Phone Email

GeneVentiv Therapeutics Inc Industry Tags

Biotechnology Research
View All Industry Tags

Companies Similar to GeneVentiv Therapeutics Inc

Analyze industry trends and opportunities by examining competitors and companies comparable to GeneVentiv Therapeutics Inc, including their performance metrics, financials, growth dynamics, and competitive benchmarks.

Company Name Revenue Number of Employees Location Founded in
3M 2 Cambridge, MA 2005
3M 7 New York, NY 2008
3M 3 New York, NY
3M 2 Knoxville, TN 2004
3M 35 Austin, TX
View More Companies

FAQ

What is the location of GeneVentiv Therapeutics Inc's headquarters?
The headquarters of GeneVentiv Therapeutics Inc are situated at 150 Fayetteville Street, Suite 2300, Raleigh NC
What is GeneVentiv Therapeutics Inc's official website?
The official website of GeneVentiv Therapeutics Inc can be found at geneventiv.com.
What is GeneVentiv Therapeutics Inc's current revenue?
As of April 2024, GeneVentiv Therapeutics Inc's annual revenue reached $3B.
How many employees does GeneVentiv Therapeutics Inc currently have?
GeneVentiv Therapeutics Inc employs approximately 2+ people as of April 2024
Which industries is GeneVentiv Therapeutics Inc primarily operating in?
GeneVentiv Therapeutics Inc operates in the following industries: Biotechnology, Pharmaceutical, Therapeutics
Who is the CEO of GeneVentiv Therapeutics Inc?
GeneVentiv Therapeutics Inc's CEO is Damon Race
What are GeneVentiv Therapeutics Inc's industry tags?
GeneVentiv Therapeutics Inc's industry tags include: Biotechnology Research

Employee Directory

Key Employees

Rob Limehouse

Member Board of Directors

Phone Email

Paris Margaritis

Chief Scientific Officer

Phone Email